FDA Recommends DEA Schedule 7-Hydroxymitragynine as Schedule I
The Food and Drug Administration has formally recommended that the DEA classify 7-hydroxymitragynine, a potent kratom-derived alkaloid, as a Schedule I controlled substance, citing concerns over its opioid-like potency a...
The FDA has suggested that 7-hydroxymitragynine, a strong compound found in kratom, should be treated like other highly controlled drugs. If the DEA follows through with this recommendation, it could make it illegal to sell or distribute products containing this compound. As a kratom distributor, you'll need to keep an eye on these developments, as they could impact your business.